Helix Aims to Deliver 'Sequence Once, Query Often' Goal to Consumers | GenomeWeb

NEW YORK (GenomeWeb) – Consumer genomics company Helix launched this week with $100 million in investments from Illumina, Warburg Pincus, and Sutter Hill Ventures, with the goal of making sequencing available to consumers.

The San Francisco-based company plans to open a CLIA certified, CAP accredited, and HIPAA compliant laboratory in San Diego where it will offer next-generation sequencing and analysis on Illumina platforms. Helix plans to launch its first products in 2016.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.

Sponsored by

This webinar will discuss a project that sought to understand the parent-of-origin epigenetic mechanisms that regulate seed development in plants, with a particular emphasis on differentiating the maternal or paternal origin of epigenetics marks.

Sponsored by

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.